World Health Organization Classification of Tumors – 5th Edition (2021) Thoracic tumors. WHO editorial board. IARC, Lyon, France

Morgan AD, Mackenzie DH (1964) Clear-cell carcinoma of the lung. J Pathol Bacteriol 87:25–27. https://doi.org/10.1002/path.1700870104

Article  CAS  PubMed  Google Scholar 

Edwards C, Carlile A (1985) Clear cell carcinoma of the lung. J Clin Pathol 38(8):880–885. https://doi.org/10.1136/jcp.38.8.880

Article  CAS  PubMed  PubMed Central  Google Scholar 

Katzenstein AL, Prioleau PG, Askin FB (1980) The histologic spectrum and significance of clear-cell change in lung carcinoma. Cancer 45(5):943–947. https://doi.org/10.1002/1097-0142(19800301)45:5%3c943::aid-cncr2820450518%3e3.0.co;2-7

Article  CAS  PubMed  Google Scholar 

Yousem SA (2013) Immunohistochemical and molecular characterization of clear cell carcinoma of the lung. Hum Pathol 44(11):2467–2474. https://doi.org/10.1016/j.humpath.2013.06.005

Article  CAS  PubMed  Google Scholar 

Gu C, Pan X, Wang R, Li Y, Shen X, Shi J, Chen H (2016) Analysis of mutational and clinicopathologic characteristics of lung adenocarcinoma with clear cell component. Oncotarget 7(17):24596–603. https://doi.org/10.18632/oncotarget.8258

Article  PubMed  PubMed Central  Google Scholar 

Eldessouki I, Gaber O, Riaz MK, Wang J, Abdel Karim N (2018) Clinical presentation and treatment options for clear cell lung cancer: University of Cincinnati a case series and literature review of clear cell lung cancer. Asian Pac J Cancer Prev 19(9):2373–2376. https://doi.org/10.22034/APJCP.2018.19.9.2373

Article  PubMed  PubMed Central  Google Scholar 

Suster D, Mackinnon AC, Ronen N, Mejbel HA, Harada S, Suster S (2023) Non-small cell lung carcinoma with clear cell features and FGFR3::TACC3 gene rearrangement: clinicopathologic and next generation sequencing study of 7 cases. Am J Surg Pathol. https://doi.org/10.1097/PAS.0000000000002167. (Advanceonlinepublication)

Article  PubMed  Google Scholar 

Suster D, Ronen N, Suster S. Pseudosquamous adenocarcinoma of the lung: clinicopathologic and immunohistochemical study of 10 cases. [Accepted for publication in Am J Surg Path]

Wang R, Wang L, Li Y, Shen L, Shen X, Pan Y et al (2014) FGFR1/3 tyrosine kinase fusions define a unique molecular subtype of non-small cell lung cancer. Clin Cancer Res 20:4107–4114

Article  CAS  PubMed  Google Scholar 

Capelleti M, Dodge ME, Ercan D, Hammerman PS, Park SI, Kim J et al (2014) Identification of recurrent FGFR3-TACC3 fusion oncogenes from lung adenocarcinoma. Clin Cancer Res 20:6551–6558

Article  Google Scholar 

Xue J, Chen W, Xu W, Xu Z, Li X, Qi F, Wang Z (2021) Patterns of metastases in patients with clear cell renal cell carcinoma – A population-based analysis. Cancer Med 10:173–187

Article  CAS  PubMed  Google Scholar 

Wei H, Miao J, Cui J, Zheng W, Chen X, Zhang Q, Liu F, Mao Z, Qiu S, Zhang D (2021) The prognosis and clinicopathologic features of different distant metastases patterns in renal cell carcinoma: analysis based on the SEER database. Sci Rep 11:17822

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tong G-X, Yu WM, Beaubier NT, Weeden EM, Hamela-Bena D, Mansukhani MM, O’Toole KM (2009) Expression of PAX8 in normal and neoplastic renal tissues: an immunohistochemical study. Mod Pathol 22:1218–1227

Article  CAS  PubMed  Google Scholar 

Yasir S, Herrera L, Gomez-Fernandes C, Reis IM, Umar S, Leveilee R, Kava B, Jorda M (2012) CD10+ and CK7/RON- immunophenotype distinguishes renal cell carcinoma, conventional type with eosinophilic morphology from its mimickers. Appl Immunohistochem Mol Morphol 20:454–461

Article  CAS  PubMed  Google Scholar 

Mentrikoski MJ, Wendroth SM, Wick MR (2014) Immunohistochemical distinction of renal cell carcinoma from other carcinomas with clear cell histomorphology: utility of CD10 and CA-125 in addition to PAX2, PAX-8, RCCma, and adipophilin. Appl Immunohistochem Mol Morphol 22:635–641

Article  CAS  PubMed  Google Scholar 

Kubo T, Hirohashi Y, Fujita H, Sugita S, Kikuchi Y, Shinkawa T et al (2018) Occult ovarian clear-cell carcinoma diagnosed as primary adenocarcinoma of the lung: a case report of a diagnostic pitfall for clinicians and pathologists. Respir Med Case Rep 25:306–308

PubMed  PubMed Central  Google Scholar 

Anglesio MS, Carey MS, Kobel M, Mackay H, Huntsman DG (2011) Clear cell carcinoma of the ovary: a report from the first ovarian clear cell symposium, June 24th, 2010. Gynecol Oncol 121:407–415

Article  PubMed  Google Scholar 

DeLair D, Oliva E, Kobel M, Macias A, Gilks CB, Soslow RA (2011) Morphologic spectrum of immunohistochemically characterized clear cell carcinoma of the ovary: a study of 155 cases. Am J Surg Pathol 35:36–44

Article  PubMed  Google Scholar 

Yamashita Y, Nagasaka T, Naiki-Ito A, Sato S, Suzuki S, Toyokuni A, Ito M, Takahashi S (2015) Napsin A is a specific marker for ovarian clear cell adenocarcinoma. Mod Pathol 28:111–117

Article  CAS  PubMed  Google Scholar 

Nakatani Y, Kitamura H, Inayama Y, Kamijo S, Nagashima Y, Shimoyama K, Nakamura N, Sano J, Ogawa N, Shibagaki T, Resl M, Mark EJ (1998) Pulmonary adenocarcinomas of the fetal lung type: a clinicopathologic study indicating differences in histology, epidemiology, and natural history of low-grade and high-grade forms. Am J Surg Pathol 22:399–411

Article  CAS  PubMed  Google Scholar 

Sato S, Koike T, Yamato Y, Yoshiya K, Honma K, Tsukada H (2006) Resected well-differentiated fetal pulmonary adenocarcinoma and summary of 25 cases reported in Japan. Jpn J Thorac Cardiovasc Surg 54:539–542

Article  PubMed  Google Scholar 

Nakatani Y, Masudo K, Miyagi Y, Inayama Y, Kawano N, Tanaka Y, Kato K, Ito T, Kitamura H, Nagashima Y, Yamanaka S, Nakamura N, Sano J, Ogawa N, Ishiwa N, Notohara K, Resl M, Mark EJ (2002) Aberrant nuclear localization and gene mutation of beta-catenin in low-grade adenocarcinoma of fetal lung type: up-regulation of the Wnt signaling pathway may be a common denominator for the development of tumors that form morules. Mod Pathol 15(6):617–624. https://doi.org/10.1038/modpathol.3880575

Article  PubMed  Google Scholar 

Thakur S, Nambirajan A, Larsen BT, Butt YM, Roden AC, Kuman S, Jain D (2023) Primary pulmonary hyalinizing clear cell carcinoma: case series with review of literature. Int J Surg Pathol 31:1187–1194

Article  CAS  PubMed  Google Scholar 

Roden AC (2021) Recent updates in salivary gland tumors of the lung. Semin Diagn Pathol 38:98–108

Article  PubMed  Google Scholar 

Takamatsu M, Sato Y, Muto M, Nagano H, Ninomiya H, Sakakibara R, Baba S, Sakata S, Tekeuchi K, Okumura S, Ishikawa Y (2018) Hyalinizing clear cell carcinoma of bronchial gland: presentation of three cases and pathologic comparisons with salivary gland counterparts and bronchial mucoepidermoid carcinoma. Mod Pathol 31:923–933

Article  PubMed  Google Scholar 

Gaffey MJ, Mills SE, Zarbo RJ, Ross GW, Sale GE, Kulander BG, Visscher DW, Yousem SA, Colby TV (1990) Clear cell tumor of the lung. A clinicopathologic, immunohistochemical, and ultrastructural study of 8 cases. Am J Surg Pathol 14:248–259

Article  CAS  PubMed  Google Scholar 

Thway K, Fisher C (2015) PEComa: morphology and genetics of a complex tumor family. Ann Diagn Pathol 19:359–368

Article  PubMed  Google Scholar 

Chen YB, Guo L-C, Huang JA, Ji C, Ling CH (2014) Clear cell tumor of the lung: a retrospective analysis. Am J Med Sci 347:50–53

Article  PubMed  Google Scholar 

Argani P, Aulmann S, Illei PB, Netto GJ, Ro J, Cho HY, Dogan S, Ladanyi M, Martignoni G, Goldblum JR, Weiss SW (2010) A distinctive subset of PEComas harbor TFE3 gene fusions. Am J Surg Pathol 15:644–653

Google Scholar 

Falconieri G, Mirra M, Michal M, Suster S (2013) Hemangioblastoma-like clear cell stromal tumor of lung. Adv Anat Pathol 20:130–135

Article  PubMed  Google Scholar 

Lindholm KE, Moran CA (2020) Hemangioblastoma-like clear cell stromal tumor of the lung: a clinicopathologic and immunohistochemical study of 5 cases. Am J Surg Pathol 44:771–775

Article  PubMed  Google Scholar 

Agaimy A, Stoehr R, Michal M, Christopoulos P, Winter H, Zhang L, Stenzinger A, Michal M, Mechtershwimer G, Antonescu CR (2021) Recurrent YAP1-TFE3 gene fusions in clear cell stromal tumor. Am J Surg Pathol 45:1541–1549

Article  PubMed  PubMed Central  Google Scholar 

Komiya T, Guddati AK, Nakanishi Y (2019) Clear cell adenocarcinoma of the lung: a SEER analysis. Transl Lung Cancer Res 8:187–191

Article  PubMed  PubMed Central  Google Scholar 

Ke SJ, Wang P, Xu B (2019) Clear cell adenocarcinoma of the lung: a population-based study. Cancer Manag Res 11:1003–1012

Article  PubMed  PubMed Central  Google Scholar